메인콘텐츠 바로가기 메뉴영역 바로가기
하이로닉 로고

하이로닉 인터내셔널 웹사이트로 이동합니다.
인터내셔널 웹사이트에는 수출용 제품으로 대한민국에서 허가하지 않은 장비 및 서비스 내용을 포함하고 있습니다. 해당 내용은 대한민국의 의료기기 광고 심의, 규제를 받지 않습니다.

인터내셔널 웹사이트 →

It goes to the HIRONIC INTL. website.
The Intrrnation Web Site contains equipment and services that are not authorized by the Republic of Korea These contents are not subject to review and regulation of medical devices in Korea.

International Website →
닫기
하이로닉 로고

하이로닉 US 웹사이트로 이동합니다.
US 웹사이트의 내용은 "FDA"로 부터 허가승인된 품목의 제품 정보에 관한 것으로, 대한민국의 소비자 보호를 위한 국내법 의료기기의 광고 심의, 규제를 받지 않습니다.

US 웹사이트 →

It goes to the HIRONIC US website.
The contents of the US web page are about product information of items approved for "FDA". They are not subject to advertising deliberation and regulation of domestic law medical devices for consumer protection in Korea.

US Website →
닫기
하이로닉 로고

하이로닉 EU 웹사이트로 이동합니다.
EU 웹사이트의 내용은 "CE MDD 또는 CE MDR"로 부터 허가승인된 품목의 제품 정보에 관한 것으로, 대한민국의 소비자 보호를 위한 국내법 의료기기의 광고 심의, 규제를 받지 않습니다.

EU 웹사이트 →

It goes to the HIRONIC EU website.
The contents of the EU(European) web page are about product information of items approved for "CEMDD or CEMDR" in EU countries. They are not subject to advertising deliberation and regulation of domestic law medical devices for consumer protection in Korea.

EU Website →
닫기
NEWS

총 242개의 게시물이 있습니다.

NEWS 목록 : 번호, 제목, 첨부, 작성일, 조회로 구성
Hironic, a leading innovator of medical aesthetic laser and energy devices, announced that the world’s first HIFU urinary incontinence treatment clinical study using Ultra Vera™ was presented at the 18th Japanese Society of Female Pelvic Floor Medicine (JFPFM) held in Kitakyushu from June 11th to 12th.   At the Kitakyushu International Conference Center which seats 500 attendees, Dr. Yuki Sekiguchi, chairman of the LUNA Clinic, stated, “Although this was not a major-scale clinical study, it was enough to gain my confidence that the Ultra Vera provided effective treatment of urinary incontinence over the duration of the clinical. Because even a nonsurgical treatment can produce such remarkable results, I felt it was worth reporting the results to the Society. Hironic official said the Ultra Vera was originally developed as a device for vaginal tightening, but it has been proven to effectively treat urinary incontinence. Hironic will continue to perform additional clinical studies and do its best to make Ultra Vera a breakthrough treatment for many patients suffering from urinary incontinence.   Society of Female Pelvic Floor Medicine (previously Urogynecology) is a renowned Japanese society of professional gynecologists, urologists and related surgeons and nurses. It has been conducting research related to various female pelvic disease and treatment including the uterus, vagina, bladder and urinary incontinence. With a majority of 200 out of 350 members attending this event, nonsurgical HIFU treatment will continue to raise high interest in Japan. Dr. Sekiguchi, a highly influential expert in female urology, is currently the director of LUNA Clinic. Established in 2005, LUNA Clinic is located in Yokohama near Tokyo and provides gynecology and urology clinical services for female patients.   Recognized as a pioneer in South Korea’s medical aesthetics market, Hironic has been setting itself apart from the competition by successfully developing and launching innovative products. In particular, Easymo Graft, a nonsurgical FUE (Follicular Unit Extraction) hair transplant device, and Ultra Vera, the world’s first HIFU device for vaginal tightening, have raised much interest in both domestic and overseas market, and Hironic expects both products to contribute significantly to its revenue growth in the second half. Since medical devices can be imported legally in Japan with just a doctor’s license, Hironic further expects that Ultra Vera’s positive clinical results will lead to sales growth in Japan. 
2016-10-05
Hironic (CEO Jin-Woo Lee, www.hironic.com), a leading innovator of medical aesthetic laser and energy devices, announced today the launch of ‘JUVINA’ filler in order to penetrate the global facial aesthetics market. As an industry leader in medical aesthetics with a strong global network and customer base, Hironic now plans to expand its filler business through a strategic partnership with Pronexx.   Hironic’s business strategy is to rapidly gain the filler market share by utilizing its vast network of global distributors which already sell Hironic’s lineup of medical aesthetic devices. With Hironic’s recognition among skin and plastic surgery clinics worldwide, JUVINA is expected to contribute highly to Hironic’s short-term revenue growth this year.   JUVINA provides lift to the cheeks and volume to correct and smooth smile lines. JUVINA is safe to use because it is made up of Hyaluronic Acid (HA), a natural substance found in the human body. When injected, Hyaluronic Acid enhances the skin’s elasticity and ability to retain moisture. JUVINA is injected deep into the dermis, and patients can immediately feel the difference with a more youthful-looking experience. With Hironic’s proprietary filler technology, the results are natural and long lasting. For optimal treatment of each skin area, JUVINA collection of fillers comes in 6 different variations - 3 levels of intensity (Soft, Balance and Intense), with and without Lidocaine.   Hironic plans to launch JUVINA at the end of June and will focus on overseas market development in the early stages. According to industry sources, the global facial aesthetics market is expected to grow at a CAGR of 11.6% until 2020. The dermal filler market is expected to grow 13% annually and reach $2.7 billion by 2020. Furthermore, the Chinese market is expected to grow even more explosively at a CAGR of 30%, from $ 8.4 million in 2014 to $230 million by 2018.   “We, at Hironic, are excited to finally launch JUVINA filler which we have planned for several years. Hironic will continue to provide innovative products and services to our valued customers,” said CEO Jin-Woo Lee.   Established in 2007, Hironic is a leading innovator of medical aesthetic laser and energy devices. Committed to creating value for human beauty and health, Hironic provides a diverse range of medical aesthetic products which include DOUBLO™, a skin-lifting device utilizing HIFU (High Intensity Focused Ultrasonic) technology for skin rejuvenation, MICOOL™, which permanently destroys fat cells for body shaping using Cryo Fat Reduction technology, MIRACLEAR™ for acne treatment and EASYMO GRAFT™, a non-invasive hair transplant device for effective hair loss treatment.
2016-10-05